Quest Diagnostics https://www.reuters.com/markets/companies/DGX.N” target=”_blank” rel=”noopener”>(DGX.N) on Monday launched the first direct-to-consumer blood test to detect abnormal levels of beta amyloid, a key Alzheimer’s disease protein that can appear yea…
Read More
About The Author
